Heart check for leukemia drug: healthy volunteers wanted
NCT ID NCT07162116
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 24 times
Summary
This study checks if a single dose of XY0206, a drug being developed for a type of leukemia, changes the heart's electrical activity (QTc interval) in healthy people. About 45 to 75 healthy adults aged 18-45 will take one dose of XY0206, a placebo, or a control drug, and have their heart monitored for 3 days. The goal is to ensure the drug is safe for the heart before further testing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA WITH FLT3/ITD MUTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PKUCare Luzhong Hospital
RECRUITINGZibo, Shandong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.